Table 2.

The allele and genotype distribution of rs2278426 (C/T) in the T2DM patients and control subjects

Genotype	Controls (138)	T2DM patients (150)	P a	OR (95% CI)a	P b	OR (95% CI)b
rs2278426 (C/T)
CC	104 (75.38%)	92 (61.4%)	0.03
CT	30 (21.73%)	49 (32.6%)	0.02	1.84 (1.02‐3.14)	0.007	2.41 (1.26‐4.59)
TT	4 (2.89%)	9 (6%)	0.11	2.54 (0.75‐8.53)	0.06	3.54 (0.91‐13.77)
Recessive model
CC + CT	134 (97.11%)	141 (94%)
TT	4 (2.89%)	9 (6%)	0.2	2.13 (0.74‐7.1)	0.27	2.05 (0.57‐7.36)
Dominant model
CT + TT	34 (24.62%)	58 (38.6%)	0.01	1.92 (1.16‐3.2)	0.004	2.5 (1.33‐4.71)
CC	104 (75.38%)	92 (61.4%)
Allele
C	238 (86.23%)	233 (77.66%)
T	38 (13.77%)	67 (22.34%)	0.008	1.07 (0.71‐1.61)

^a P and OR calculated by chi‐square test.

^b P and OR calculated by logistic regression test after adjustment for Age, BMI and lipid profile.